Tech Company Financing Transactions
Mirimus Funding Round
Mirimus, operating out of Brooklyn, raised $2 million from Delphi Ventures and Topspin Partners.
Transaction Overview
Company Name
Announced On
3/31/2011
Transaction Type
Venture Equity
Amount
$2,001,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
760 Parkside Ave. 206
Brooklyn, NY 11226
USA
Brooklyn, NY 11226
USA
Phone
Website
Email Address
Overview
The company makes genetically engineered animal models of disease.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Prem Premsrirut
Chief Scientific Officer
Scott Lowe
Founder
Christof Fellmann
Browse more venture capital transactions:
Prev: 3/31/2011: Sanovia venture capital transaction
Next: 3/31/2011: Principia Biopharma venture capital transaction
Share this article
About Our VC Transactions Data
Our team works diligently to record every notable VC transaction. VC investment data records reported here are derived from company press releases and news coverage. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs